|
Volumn 9, Issue 11, 2001, Pages 3065-3075
|
Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 BENZYL 4 (4 METHYLPIPERAZINYLCARBONYL)PHENOXY 1 [1 (PHENYLETHYL)AMINOCARBONYL]AZETIDIN 2 ONE;
3 BENZYLAZETIDIN 2 ONE DERIVATIVE;
4 (4 CARBOXYPHENOXY) 1 [(DIPHENYLMETHYL)AMINOCARBONYL] 3 (2 ETHOXYBENZYL)AZETIDIN 2 ONE;
AZETIDINONE DERIVATIVE;
CATHEPSIN G;
CHYMASE;
CHYMOTRYPSIN A;
ENZYME INHIBITOR;
TRYPSIN;
UNCLASSIFIED DRUG;
AZETIDINE DERIVATIVE;
FUNCTIONAL GROUP;
N [1 (1,3 BENZODIOXOL 5 YL)BUTYL] 3,3 DIETHYL 2 [4 [(4 METHYL 1 PIPERAZINYL)CARBONYL]PHENOXY] 4 OXO 1 AZETIDINECARBOXAMIDE;
ARTICLE;
DRUG DESIGN;
DRUG SPECIFICITY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
ENZYME STABILITY;
HUMAN;
IN VITRO STUDY;
NUCLEAR MAGNETIC RESONANCE;
PLASMA;
STRUCTURE ACTIVITY RELATION;
CHEMICAL REACTION;
DRUG STRUCTURE;
REACTION ANALYSIS;
AZETIDINES;
BLOOD;
CHYMASES;
DRUG DESIGN;
HUMANS;
SERINE ENDOPEPTIDASES;
SERINE PROTEINASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0034801226
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00209-7 Document Type: Article |
Times cited : (62)
|
References (29)
|